By Denny Jacob


ReShape Lifesciences received approval for a PMA supplement for its Lap-Band 2.0 FLEX from the Food and Drug Administration.

The approval is expected to be a growth catalyst for the weight loss and metabolic health solutions company's Lap-Band franchise, said Chief Executive Paul Hickey. He added that the company is preparing for its U.S. product launch of the latest iteration of the Lap-Band.

The FDA-approved Lap-Band System provides minimally invasive, long-term treatment of obesity, said ReShape.


Write to Denny Jacob at denny.jacob@wsj.com


(END) Dow Jones Newswires

12-12-23 1630ET